Literature DB >> 14621965

Solubility enhancement of Cox-2 inhibitors using various solvent systems.

N Seedher1, S Bhatia.   

Abstract

This study examined the solubility enhancement of 4 cox-2 inhibitors, celecoxib, rofecoxib, meloxicam, and nimesulide, using a series of pure solvents and solvent mixtures. Water, alcohols, glycols, glycerol, and polyethylene glycol 400 (PEG 400) were used as solvents and water-ethanol, glycerol-ethanol, and polyethylene glycol-ethanol were used as mixed-solvent systems. A pH-solubility profile of drugs was obtained in the pH range 7.0 to 10.9 using 0.05 M glycine-sodium hydroxide buffer solutions. Lower alcohols, higher glycols, and PEG 400 were found to be good solvents for these drugs. The aqueous solubility of celecoxib, rofecoxib, and nimesulide could be enhanced significantly by using ethanol as the second solvent. Among the mixed-solvent systems, PEG 400- ethanol system had highest solubilization potential. In the case of meloxicam and nimesulide, solubility increased significantly with increase in pH value. Physico-chemical properties of the solvent such as polarity, intermolecular interactions, and the ability of the solvent to form a hydrogen bond with the drug molecules were found to be the major factors involved in the dissolution of drugs by pure solvents. The greater the difference in the polarity of the 2 solvents in a given mixed solvent, the greater was the solubilization power. However, in a given mixed-solvent system, the solubilization power could not be related to the polarity of the drugs. Significance of the solubility data in relation to the development of formulations has also been discussed in this study.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14621965      PMCID: PMC2750626          DOI: 10.1208/pt040333

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  16 in total

1.  Combined effect of cosolvent and cyclodextrin on solubilization of nonpolar drugs.

Authors:  P Li; L Zhao; S H Yalkowsky
Journal:  J Pharm Sci       Date:  1999-11       Impact factor: 3.534

2.  Selective COX-2 inhibition.

Authors:  S Silas; D O Clegg
Journal:  Bull Rheum Dis       Date:  1999

3.  Solubilization by cosolvents. Establishing useful constants for the log-linear model.

Authors:  Jeffrey Millard; F Alvarez-Núñez; S Yalkowsky
Journal:  Int J Pharm       Date:  2002-10-01       Impact factor: 5.875

Review 4.  Organic solvents for pharmaceutical parenterals and embolic liquids: a review of toxicity data.

Authors:  F Mottu; A Laurent; D A Rufenacht; E Doelker
Journal:  PDA J Pharm Sci Technol       Date:  2000 Nov-Dec

5.  Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans.

Authors:  M Depré; E Ehrich; A Van Hecken; I De Lepeleire; A Dallob; P Wong; A Porras; B J Gertz; P J De Schepper
Journal:  Eur J Clin Pharmacol       Date:  2000-05       Impact factor: 2.953

6.  Solubilization by cosolvents I: organic solutes in propylene glycol-water mixtures.

Authors:  S H Yalkowsky; J T Rubino
Journal:  J Pharm Sci       Date:  1985-04       Impact factor: 3.534

7.  Inclusion complexation of nimesulide with beta-cyclodextrins.

Authors:  P R Vavia; N A Adhage
Journal:  Drug Dev Ind Pharm       Date:  1999-04       Impact factor: 3.225

8.  Solubilization of fluasterone.

Authors:  L Zhao; P Li; S H Yalkowsky
Journal:  J Pharm Sci       Date:  1999-10       Impact factor: 3.534

9.  Solubilization of cyclosporin A.

Authors:  Y Ran; L Zhao; Q Xu; S H Yalkowsky
Journal:  AAPS PharmSciTech       Date:  2001-01-18       Impact factor: 3.246

10.  Pharmaceutical development and manufacturing of a parenteral formulation of a novel antitumor agent, VNP40101M.

Authors:  G Krishna; W F Hodnick; W Lang; X Lin; S Karra; J Mao; B Almassian
Journal:  AAPS PharmSciTech       Date:  2001-08-26       Impact factor: 3.246

View more
  29 in total

1.  Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion.

Authors:  Omaima A Sammour; Mohammed A Hammad; Nagia A Megrab; Ahmed S Zidan
Journal:  AAPS PharmSciTech       Date:  2006-06-16       Impact factor: 3.246

2.  Effect of oppositely charged polymer and dissolution medium on swelling, erosion, and drug release from chitosan matrices.

Authors:  Kiran S Bhise; Ravindra S Dhumal; Bhaskar Chauhan; Anant Paradkar; Shivajirao S Kadam
Journal:  AAPS PharmSciTech       Date:  2007-06-15       Impact factor: 3.246

3.  Electrostatic control of the overall shape of calmodulin: numerical calculations.

Authors:  A Isvoran; C T Craescu; E Alexov
Journal:  Eur Biophys J       Date:  2007-02-07       Impact factor: 1.733

4.  In vitro and in vivo evaluation of proniosomes containing celecoxib for oral administration.

Authors:  Mohamed Nasr
Journal:  AAPS PharmSciTech       Date:  2010-01-08       Impact factor: 3.246

5.  The safety, pharmacokinetics, and efficacy of intraocular celecoxib.

Authors:  Stephen J Kim; Hassanain Toma; Rohan Shah; Uday B Kompella; Sunil K Vooturi; Jinsong Sheng
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-10       Impact factor: 4.799

6.  Optimization of photocatalytic degradation of meloxicam using titanium dioxide nanoparticles: application to pharmaceutical wastewater analysis, treatment, and cleaning validation.

Authors:  Ahmed H Nadim; Medhat A Al-Ghobashy; Marianne Nebsen; Mostafa A Shehata
Journal:  Environ Sci Pollut Res Int       Date:  2015-05-27       Impact factor: 4.223

7.  Silica-lipid hybrid (SLH) versus non-lipid formulations for optimising the dose-dependent oral absorption of celecoxib.

Authors:  Angel Tan; Andrew K Davey; Clive A Prestidge
Journal:  Pharm Res       Date:  2011-05-11       Impact factor: 4.200

8.  Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.

Authors:  Aniruddha C Amrite; Surya P Ayalasomayajula; Narayan P S Cheruvu; Uday B Kompella
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-03       Impact factor: 4.799

9.  Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique.

Authors:  Mukesh Gohel; Madhabhai Patel; Avani Amin; Ruchi Agrawal; Rikita Dave; Nehal Bariya
Journal:  AAPS PharmSciTech       Date:  2004-04-26       Impact factor: 3.246

10.  Various solvent systems for solubility enhancement of enrofloxacin.

Authors:  Neelam Seedher; Pooja Agarwal
Journal:  Indian J Pharm Sci       Date:  2009-01       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.